Literature DB >> 4014386

Radiation therapy for thyroid eye diseases.

T Hurbli, D H Char, J Harris, K Weaver, F Greenspan, G Sheline.   

Abstract

Sixty-two patients (28 men and 34 women, 26 to 84 years old) with thyroid ophthalmopathy were treated with approximately 20 Gy of fractionated photon irradiation. Eight of 14 patients with motility problems improved after treatment. Ten of 14 with thyroid optic neuropathy improved or stabilized, but four had recurrences within five months after completion of irradiation. Generally, patients who had disease durations of less than six months responded better than those with more long-term ocular changes.

Entities:  

Mesh:

Year:  1985        PMID: 4014386     DOI: 10.1016/s0002-9394(14)76027-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.

Authors:  Kimberley P Cockerham; John S Kennerdell
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Ophthaproblem. Thyroid-related eye disease.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-04       Impact factor: 3.275

3.  Graves' ophthalmopathy: III. Effect of transantral orbital decompression on optic neuropathy.

Authors:  E S Hallin; S E Feldon; J Luttrell
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

4.  Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?

Authors:  M P Mourits; L Koorneef; A M van Mourik-Noordenbos; H M van der Meulen-Schot; M F Prummel; W M Wiersinga; A Berghout
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

5.  Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.

Authors:  Chan Jeon; Jae Ho Shin; Kyung In Woo; Yoon-Duck Kim
Journal:  Korean J Ophthalmol       Date:  2012-03-22

6.  Radiotherapy in the treatment of Graves ophthalmopathy-to do it or not?

Authors:  Aneta Zygulska
Journal:  J Ocul Biol Dis Infor       Date:  2009-10-06

7.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

8.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988

9.  [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; G Gusek-Schneider; S Barth; J Hensen; F Wolf; G O Naumann; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 4.033

10.  Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy.

Authors:  Sang Min Lee; Jung Ho Im; Hyun Soo Shin; Helen Lew
Journal:  BJR Open       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.